Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 4 of the 13 calendar months from Oct 2025 to Oct 2026: Dec 2025, Jan 2026, Feb 2026 and Jul 2026.
- Largest single sale: $2.1M (4,500 shares) of Vertex Pharmaceuticals on Jan 7, 2026. Filing
- Last sale before this period: Mar 10, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Vertex Pharmaceuticals (VRTX) | EVP, Chief Reg. & Quality Off. | Oct 3, 2019 | Jul 23, 2026 |
| Odyssey Therapeutics, Inc. (ODTX) | Director | May 7, 2026 | May 11, 2026 |
Also a director at
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jul 21, 2026, Vertex Pharmaceuticals: 8,251 shares granted. 1 filing: 1
- Jul 2, 2026, Vertex Pharmaceuticals: sold 1,500 shares for $787K, under a disclosed plan. 1 filing: 1
- Feb 25, 2026, Vertex Pharmaceuticals: sold 260 shares for $126K, under a disclosed plan. 1 filing: 1
- Feb 24, 2026, Vertex Pharmaceuticals: 1,627 shares withheld by the company for taxes. 1 filing: 1
- Feb 18, 2026, Vertex Pharmaceuticals: sold 368 shares for $174K, under a disclosed plan. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.